Browse by day - Tuesday, September 27, 2011
  Session Title Type Day Time Room
357.
Pulmonary infections and sepsis Oral Presentation Tuesday 08:30 - 10:30 Elicium 1
358.
E-learning Oral Presentation Tuesday 08:30 - 10:30 Forum
359.
Important new developments in paediatric respiratory physiology Oral Presentation Tuesday 08:30 - 10:30 Room 5.2
360.
New insights in the incidence, variation and risk factors of asthma Oral Presentation Tuesday 08:30 - 10:30 Room 3.1
361.
Growth factors and fibrogenesis: are they good, bad or both? Oral Presentation Tuesday 08:30 - 10:30 Room 3.2
362.
Obstructive sleep apnoea   in children and adults Oral Presentation Tuesday 08:30 - 10:30 Room 4.2
363.
Sleep and weight: heavy under pressure Oral Presentation Tuesday 08:30 - 10:30 Emerald
364.
Physical activity monitors: from toy to valid tool? Oral Presentation Tuesday 08:30 - 10:30 Room D203-204
365.
Asthma: basic science and clinical studies Poster Discussion Tuesday 08:30 - 10:30 Room G102-103
366.
Inflammation and genes in childhood asthma Poster Discussion Tuesday 08:30 - 10:30 Room G104-105
367.
Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Poster Discussion Tuesday 08:30 - 10:30 Room G106-107
368.
Environmental exposure and disease mechanisms Poster Discussion Tuesday 08:30 - 10:30 Room E104-106
369.
Experimental pulmonary hypertension Poster Discussion Tuesday 08:30 - 10:30 Room E102
370.
Biomarkers and exacerbations of asthma and COPD Poster Discussion Tuesday 08:30 - 10:30 Room D201-202
378.
Non-tuberculous mycobacteria pulmonary infections Oral Presentation Tuesday 10:45 - 12:45 Elicium 1
379.
Early wheezing conditions in childhood Oral Presentation Tuesday 10:45 - 12:45 Forum
380.
Late-Breaking Abstracts Session: New mechanisms in airway disease Oral Presentation Tuesday 10:45 - 12:45 Room 5.2
381.
Highlights in lung function 2011 Oral Presentation Tuesday 10:45 - 12:45 Room 3.1
382.
New treatments for airway disease Oral Presentation Tuesday 10:45 - 12:45 Room 3.2
383.
Pathobiology of experimental pulmonary hypertension Oral Presentation Tuesday 10:45 - 12:45 Room 4.2
384.
Outdoor air pollution studies Oral Presentation Tuesday 10:45 - 12:45 Emerald
385.
Understanding disease and drug mechanisms Oral Presentation Tuesday 10:45 - 12:45 Room D203-204
386.
Obstructive sleep apnoea as a comorbidity Poster Discussion Tuesday 10:45 - 12:45 Room G102-103
387.
Challenges in chronic disease management: helping individuals with chronic lung disease remain stable Poster Discussion Tuesday 10:45 - 12:45 Room G104-105
388.
Insight into mechanisms of respiratory infections Poster Discussion Tuesday 10:45 - 12:45 Room G106-107
389.
Phenotyping and monitoring of airway diseases Poster Discussion Tuesday 10:45 - 12:45 Room E104-106
390.
Treatment beyond inhalers: endoscopic lung volume reduction Poster Discussion Tuesday 10:45 - 12:45 Room E102
391.
Molecular markers: diagnosis and management of malignant pleural effusions Poster Discussion Tuesday 10:45 - 12:45 Room D201-202
393.
COPD diagnosis Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-1
394.
COPD mechanisms Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-2
395.
New insights in management of interstitial and vascular lung diseases Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-3
396.
What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-4
397.
Challenges in rehabilitation: some old dilemmas revisited with some solutions? Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-5
398.
Imaging in oncology and infectious diseases Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-6
399.
The basic and the future: pure diagnostic or dedicated wavelengths play Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-7
400.
A little bit of everything: interventional pneumology Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-8
401.
Different profiles of sarcoidosis and other granulomatous disorders Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-9
402.
Clinical perspectives in several interstitial diseases Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-10
403.
Quality of diagnosis and assessment in primary care Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-11
404.
Recent advances in noninvasive ventilation used for treating acute respiratory failure Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-12
405.
Lung development and neoplasia Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-13
406.
COPD: clinical studies and animal cell models Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-14
407.
Immunology and cell biology of asthma and COPD Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-15
408.
Phagocytes and dendritic cells Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-16
409.
Cell biology of lung disease Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-17
410.
Novel mechanisms in lung injury Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-18
411.
Obstructive sleep apnoea: clinical aspects II Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-19
412.
Prediction of pulmonary thromboembolism Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-20
413.
Asthma management and response Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-21
414.
Drug delivery and pharmacokinetics II Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-22
415.
Airways disease comorbidities and general aspects Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-23
416.
Update on monitoring airway diseases Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-24
417.
Bronchial hyperresponsiveness and exhaled and sputum biomarkers Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-25
418.
Treatment strategies, systemic manifestations and biomarkers in airway diseases Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-26
419.
Diagnosis and treatment of inflammatory respiratory diseases Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-27
420.
Experimental modulation of airway inflammation Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-28
421.
Respiratory epidemiology: quality of life, therapy and socioeconomics Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-29
422.
Respiratory epidemiology: prevalence, incidence and remission Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-30
423.
Respiratory epidemiology: methods, definitions and phenotypes Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-31
424.
Work-related respiratory diseases and specific exposures Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-32
425.
Work, the environment and respiratory disease Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-33
426.
Anti-smoking interventions: prevention and treatment Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-34
427.
Epidemiology of smoking and smoking cessation interventions Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-35
428.
Coping and lifestyle in childhood asthma Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-36
429.
Biological correlates and comorbidities of childhood asthma/allergy Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-37
430.
Cystic fibrosis: clinical and laboratory studies Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-38
431.
Issues in paediatric and neonatal intensive care Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-39
432.
General thoracic surgery II Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-40
433.
Influenza A (H1N1): lessons after the epidemic Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-41
434.
Challenges in tuberculosis control Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-42
435.
Novel strategies for the diagnosis of tuberculosis Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-43
436.
Treatment of tuberculosis and adverse drug reactions Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-44
437.
Quality management for lung cancer patients Thematic Poster Session Tuesday 12:50 - 14:40 Hall 2-45
460.
Late-Breaking Abstracts Session: New treatments and targets for airway disease Oral Presentation Tuesday 14:45 - 16:45 Forum
461.
Innovative diagnostic methods for lung cancer Oral Presentation Tuesday 14:45 - 16:45 Room 5.2
462.
Appropriate use of antibiotics in respiratory infections in Europe (the GRACE project) Oral Presentation Tuesday 14:45 - 16:45 Room 3.1
463.
Biomarkers in sarcoidosis Oral Presentation Tuesday 14:45 - 16:45 Room 3.2
464.
Access to the periphery: solitary periphery nodule Oral Presentation Tuesday 14:45 - 16:45 Room 4.2
466.
COPD mechanisms Poster Discussion Tuesday 14:45 - 16:45 Room G102-103
467.
Cystic fibrosis: new basic, clinical and bacteriological knowledge Poster Discussion Tuesday 14:45 - 16:45 Room G104-105
468.
Rare lung diseases in children Poster Discussion Tuesday 14:45 - 16:45 Room G106-107
469.
Lung cell injury and repair Poster Discussion Tuesday 14:45 - 16:45 Room E104-106
470.
Morphological and functional imaging in obstructive airway disease Poster Discussion Tuesday 14:45 - 16:45 Room E102
471.
Disease management in specific primary care populations Poster Discussion Tuesday 14:45 - 16:45 Room D201-202